Digital Health Today shines a spotlight on the entrepreneurs, innovators, and organizations that dare to revolutionize healthcare
Turning autoantibodies into an early-warning system to beat cancer
In episode 74, we spoke about early detection of skin cancer with Erik de Heus, the CEO of SkinVision. In that episode we talked about a smartphone app that uses AI to determine the likelihood that a mole or mark on your skin could be malignant. That technology has reviewed millions of images and has helped detect cancer in tens of thousands of people around the world. It’s a great solution and it’s making a huge impact and it will continue to hold a vital place in our fight against skin cancer. But what about cancers below our skin’s surface? What tools do we have to detect and fight those cancers that we can’t see and that may be developing inside us?
Is there a way to detect those cancers even before they form a cluster of cells large enough to be detected through a biopsy or scan?
What if we could enlist the power of our own immune system to create a sort of early warning system that could alert us when cancerous cells are present.
Well, the good news is that such a technology does exist, and it’s being used to detect cancer 4 years earlier, or sometimes even more, for a wide range of solid tumor types. And all it requires is a simple blood test.
Our guest today is going to share how these technologies work, and how they are changing the way with think about the progression, detection and treatment of cancer.
With me to talk about it is Dr Adam M Hill, he is the CEO of a leading cancer detection company called Oncimmune. Adam is a both a Clinician and Mechanical Engineer, and has spent his career at the interface of industry, academia and health systems. Early in his career, he trained in surgery in the British Army and he helped a Formula One team become a developer of health technology.
Over the last 5 years, Adam has been an early stage investor in, and advisor to, a number of health technology startups. He is also a Visiting Professor in Global Health Innovation at Imperial College London. We cover a lot of ground in this episode and Adam and his team have developed a PDF that contains the key details we talk about in this program, so be sure to grab a copy of that as well.
Today's Topics:
Links and Resources Mentioned:
This episode of Digital Health Today is made possible thanks to our sponsors. Thank you!
An important message from RadioPublic
Women and girls in low/middle-income countries are facing an urgent unmet need for modern contraception. This World Contraception Day, join guest host Sophie Park, Managing Director at G4A …
The Digital Medicine Society (DiMe) and Moffitt Cancer Center have announced they are co-hosting CancerX, a new public-private partnership effort to rapidly accelerate the pace of cancer …
In this coffee talk with AmalgamRX we dive into the challenges being faced by health systems as they work to assess, develop, and implement solutions …
I’m glad to be back on the mic and bringing you this special episode of Digital Health Today 360. Why is this episode special? Let me explain.
One of the goals of the Digital Health Today …
Technology is under the microscope, as are the behaviors of the people who develop and deploy it.
As technology impacts virtually every aspect of …
You can listen to episodes right here on the website, or if you prefer, in a podcast app. Listening in an app makes it easier to keep track of what you’ve already heard, listen without using your data plan and many other conveniences.